【ChiCTR2600126057】Reformer Pilates Improves Posture and Functional Movement Regardless of AI-Assisted Personalisation: A Randomised Study
ChiCTR2600126057
正在进行
/
/
/
2026-06-03
/
/
Postural deviations and functional movement quality in healthy recreational-trained adults
Reformer Pilates Improves Posture and Functional Movement Regardless of AI-Assisted Personalisation: A Randomised Study
Comparison of an 8-Week ChatGPT-Assisted, Weekly-Adaptive Reformer Pilates Programme with a Fixed Traditional Reformer Pilates Protocol on Postural Alignment and Functional Movement Quality in Healthy Recreational-Trained Adults: A Randomised Pre-Test/Post-Test Experimental Trial
To compare the effects of an 8-week ChatGPT-assisted, weekly-adaptive Reformer Pilates programme with a fixed instructor-designed Reformer Pilates programme of equivalent training volume on postural alignment (assessed by APECS photogrammetry at five anatomical landmarks: ears, shoulders, ASIS, knees, feet) and functional movement quality (assessed by all seven Functional Movement Screen subtests) in healthy recreational-trained adults aged 20-45 years with a minimum of 6 months prior Pilates experience. The primary hypothesis was that the AI-assisted personalisation would yield superior outcomes compared with the traditional fixed protocol.
随机平行对照
治疗新技术
Simple randomisation. The allocation sequence was generated in advance by an independent researcher, not involved in recruitment, training delivery or outcome assessment, using the Microsoft Excel RAND function (Excel 2019, Microsoft Corporation, Redmond, WA, USA). The function produces uniform pseudo-random values, which were rank-ordered to yield an unbiased group sequence with 1:1 allocation ratio.
Single-blind. Outcome assessor was blinded to group allocation throughout the study. The same trained researcher conducted all APECS photogrammetric evaluations and all FMS assessments without knowledge of participant group assignment. Participants and the instructor delivering the intervention were not blinded, as the nature of the intervention (personalised vs. fixed exercise programme) precluded participant and instructor blinding. To preserve assessor blinding, participants were explicitly instructed not to disclose their group assignment during assessment sessions, and assessment sessions for the two groups were scheduled on separate days.
/
/
15
/
2025-03-20
2025-07-01
/
1. Healthy adults aged 20-45 years; 2. Minimum of 6 months continuous prior Pilates experience (any format); 3. No orthopaedic, neurological, or musculoskeletal pathology limiting full participation in supervised exercise; 4. Willingness to commit to 16 training sessions over 8 weeks; 5. Written informed consent. 1. Healthy adults aged 20-45 years;2. Minimum of 6 months continuous prior Pilates experience (any format);3. No orthopaedic, neurological, or musculoskeletal pathology limiting full participation in supervised exercise;4. Willingness to commit to 16 training sessions over 8 weeks;5. Written informed consent.;
请登录查看1. Concurrent enrolment in another structured resistance, movement, or rehabilitation programme; 2. History of spinal surgery or vertebral fracture; 3. Current pregnancy; 4. Inability to provide informed consent.;
请登录查看Manisa Celal Bayar University (Manisa Celal Bayar Üniversitesi)
/
Manisa Celal Bayar University (Manisa Celal Bayar Üniversitesi)的其他临床试验
Manisa Celal Bayar University - Sport Science Faculty的其他临床试验
最新临床资讯
-
Nat Rev Clin Oncol|AI赋能肿瘤临床试验:从流程优化到证据生成的全景透视
智药邦2026-08-12
-
康臣药业1类新药糖肾方“芪箭颗粒”获NMPA临床研究许可
康臣药业2026-08-12
-
璎黎药业2026-08-12
-
幂方健康基金2026-08-12
-
细胞与基因治疗领域2026-08-12
-
云南白药2026-08-12
-
细胞治疗前沿2026-08-12
-
广州达博生物制品有限公司2026-08-12
-
医药笔记2026-08-12
-
医药笔记2026-08-12
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 38
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
